Bristol-Myers (BMY) will host an investor conference call at 8:30 AM, to provide details on Extension of U.S. Agreement for ABILIFY and Establishment of an Oncology Collaboration with Otsuka and related financial updates.

To access the live webcasts, log on to http://investor.bms.com

To hear the live, dial 913-312-0823; confirmation code: 3681495.

For comments and feedback: contact editorial@rttnews.com